Fiscal Year (FY) 2024 Notice of Supplemental Funding Opportunity, 68452 [2024-19021]
Download as PDF
<![CDATA[
68452
Federal Register / Vol. 89, No. 165 / Monday, August 26, 2024 / Notices
Dated: August 20, 2024.
Ann Ferrero,
Public Health Analyst.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
[FR Doc. 2024–19021 Filed 8–23–24; 8:45 am]
BILLING CODE 4162–20–P
Fiscal Year (FY) 2024 Notice of
Supplemental Funding Opportunity
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental
Health Services Administration,
Department of Health and Human
Services (HHS).
AGENCY:
Substance Abuse and Mental Health
Services Administration
Fiscal Year (FY) 2024 Notice of
Supplemental Funding Opportunity
Notice of intent to award
supplemental funding.
ACTION:
This notice is to inform the
public that the Substance Abuse and
Mental Health Services Administration
(SAMHSA) is supporting an
administrative supplement in scope of
the parent award for one eligible grant
recipient funded under the FY 2023
Provider’s Clinical Support System—
Medications for Opioid Use Disorder
(PCSS–MOUD), Notice of Funding
Opportunity (NOFO) TI–23–014. The
recipient may receive up to $1,000,000.
This supplement provides support to
the recipient with a project end date of
September 30, 2025. The supplemental
funding will be used to support
increased fees from the training
platform service as a result of an
increase in the number of practitioners
accessing training from the program.
SUMMARY:
Patti
Juliana, Substance Abuse and Mental
Health Services Administration, 5600
Fishers Lane, Rockville, MD 20857,
telephone 240–276–1195; email:
patti.juliana@samhsa.hhs.gov.
FOR FURTHER INFORMATION CONTACT:
lotter on DSK11XQN23PROD with NOTICES1
SUPPLEMENTARY INFORMATION:
Funding Opportunity Title: FY2024
Providers’ Clinical Support System—
Medications for Opioid Use Disorder
(PCSS-MOUD) TI–23–014.
Assistance Listing Number: 93.243.
Authority: Section 509 of the of the
Public Health Service Act.
Justification: The one SAMHSAfunded grant recipient of this NOFO has
experienced increased fees from its
training platform service as a result of
an increase in the number of
practitioners accessing training from the
program.
This is not a formal request for
application. Assistance will only be
provided to the one PCSS–MOUD grant
recipient funded in FY 2023 under the
Providers’ Clinical Support System—
Medications for Opioid Use Disorder
(PCSS–MOUD) [TI–23–014] based on
the receipt of a satisfactory application
and associated budget that is approved
by a review group.
VerDate Sep<11>2014
17:03 Aug 23, 2024
Jkt 262001
Substance Abuse and Mental
Health Services Administration,
Department of Health and Human
Services (HHS).
ACTION: Notice of intent to award
supplemental funding.
AGENCY:
This notice is to inform the
public that the Substance Abuse and
Mental Health Services Administration
(SAMHSA) is supporting administrative
supplements in scope of the parent
award for the 26 eligible grant recipients
funded in FY 2022 under the First
Responders-Comprehensive Addiction
and Recovery Act (FR–CARA), Notice of
Funding Opportunity (NOFO) TI–22–
008. Recipients may receive up to
$58,190 each, for a total of $1,512,940
across the program. These recipients
have a project end date for use of these
supplemental funds of September 29,
2025. The supplements will be used to
fund a Training of Trainer (ToT) model
to rapidly expand workforce
development and capacity in the arena
of preventing overdose related deaths
and adverse events within existing
projects funded under the FR–CARA
program.
FOR FURTHER INFORMATION CONTACT:
Shannon Hastings, NOFO Lead,
Division of Targeted Prevention, Center
for Substance Abuse Prevention,
Substance Abuse and Mental Health
Services Administration, 5600 Fishers
Lane, Rockville, MD 20857, DTPNOFO@samhsa.hhs.gov, Telephone:
(240) 276–1869.
SUPPLEMENTARY INFORMATION:
Funding Opportunity Title: FY 2022
First Responders-Comprehensive
Addiction and Recovery Act (FR-CARA)
TI–22–008.
Assistance Listing Number: 93.243.
Authority: Section 546 of the Public
Health Service Act, as amended, 42
U.S.C. 290ee–1.
Justification: These supplement
awards will be offered to the FY 2022
cohorts under TI–22–008. Supplemental
funding will be awarded to this cohort
that has two years remaining in awards
SUMMARY:
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
to implement their projects. FY 2022
cohorts have implemented existing
activities well positioned to be
leveraged under the ToT model. These
factors will benefit SAMHSA so that the
agency will be able to track the effects
of the ToT model over time. This work
aligns with SAMHSA’s goals of
expanding access to naloxone and other
opioid overdose reversal medications
and enhances SAMHSA’s naloxone
saturation and overdose prevention
efforts.
This is not a formal request for
application. Assistance will only be
provided to the 26 FR–CARA grant
recipients funded in FY 2022 under the
First Responders-Comprehensive
Addiction and Recovery Act NOFO (TI–
22–008) based on the receipt of a
satisfactory application and associated
budget that is approved by a review
group.
Dated: August 20, 2024.
Ann Ferrero,
Public Health Analyst.
[FR Doc. 2024–18944 Filed 8–23–24; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Fiscal Year (FY) 2024 Notice of
Supplemental Funding Opportunity
Substance Abuse and Mental
Health Services Administration,
Department of Health and Human
Services (HHS).
ACTION: Notice of intent to award
supplemental funding.
AGENCY:
This notice is to inform the
public that the Substance Abuse and
Mental Health Services Administration
(SAMHSA) is supporting administrative
supplements in scope of the parent
award for the five eligible grant
recipients funded in FY22 and FY23
under the Grants to Prevent Prescription
Drug/Opioid Overdose Program (PDO),
Notice of Funding Opportunity (NOFO)
SP–21–002. Recipients may receive up
to $279,266 each for a total of
$1,396,330 across the program. These
recipients have a project end date for
use of these supplemental funds of
September 29, 2025. The supplemental
funding will be used to fund a
comprehensive Training of Trainer
(ToT) model to enhance workforce
development and capacity in the arena
of preventing prescription drug/
overdose related deaths and adverse
SUMMARY:
E:\FR\FM\26AUN1.SGM
26AUN1
]]>Agencies
[Federal Register Volume 89, Number 165 (Monday, August 26, 2024)]
[Notices]
[Page 68452]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-19021]
[[Page 68452]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Fiscal Year (FY) 2024 Notice of Supplemental Funding Opportunity
AGENCY: Substance Abuse and Mental Health Services Administration,
Department of Health and Human Services (HHS).
ACTION: Notice of intent to award supplemental funding.
-----------------------------------------------------------------------
SUMMARY: This notice is to inform the public that the Substance Abuse
and Mental Health Services Administration (SAMHSA) is supporting an
administrative supplement in scope of the parent award for one eligible
grant recipient funded under the FY 2023 Provider's Clinical Support
System--Medications for Opioid Use Disorder (PCSS-MOUD), Notice of
Funding Opportunity (NOFO) TI-23-014. The recipient may receive up to
$1,000,000. This supplement provides support to the recipient with a
project end date of September 30, 2025. The supplemental funding will
be used to support increased fees from the training platform service as
a result of an increase in the number of practitioners accessing
training from the program.
FOR FURTHER INFORMATION CONTACT: Patti Juliana, Substance Abuse and
Mental Health Services Administration, 5600 Fishers Lane, Rockville, MD
20857, telephone 240-276-1195; email: [email protected].
SUPPLEMENTARY INFORMATION:
Funding Opportunity Title: FY2024 Providers' Clinical Support
System--Medications for Opioid Use Disorder (PCSS-MOUD) TI-23-014.
Assistance Listing Number: 93.243.
Authority: Section 509 of the of the Public Health Service Act.
Justification: The one SAMHSA-funded grant recipient of this NOFO
has experienced increased fees from its training platform service as a
result of an increase in the number of practitioners accessing training
from the program.
This is not a formal request for application. Assistance will only
be provided to the one PCSS-MOUD grant recipient funded in FY 2023
under the Providers' Clinical Support System--Medications for Opioid
Use Disorder (PCSS-MOUD) [TI-23-014] based on the receipt of a
satisfactory application and associated budget that is approved by a
review group.
Dated: August 20, 2024.
Ann Ferrero,
Public Health Analyst.
[FR Doc. 2024-19021 Filed 8-23-24; 8:45 am]
BILLING CODE 4162-20-P
